Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineered polyallylamine nanoparticles for efficient in vitro transfection.

Atul Pathak1, Anita Aggarwal, Raj K Kurupati

  • 1Institute of Genomics and Integrative Biology, Delhi University Campus, Mall Road, Delhi 110007, India.

Pharmaceutical Research
|March 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-processed foods, lifestyle management, and cardiovascular diseases: A clinical consensus statement of the European Society of Cardiology Council for Cardiology Practice and the European Association of Preventive Cardiology of the European Society of Cardiology.

European heart journal·2026
Same author

The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension.

Drugs·2026
Same author

Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data.

Thrombosis research·2025
Same author

Prime Time for (im) Precision Medicine: From Randomized Clinical Trials to Real-World Evidence.

European journal of preventive cardiology·2025
Same author

European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice.

Nature reviews. Cardiology·2025
Same author

Feasibility and safety of renal nerve stimulation using the direct wire pacing (DWP®) technique during renal denervation procedure: A first-in-human study.

Cardiovascular revascularization medicine : including molecular interventions·2025
Same journal

Design, Synthesis and Characterization of Anti-CTLA4 Peptide Conjugated Gemcitabine Prodrug Nanoparticles for Targeted Lung Cancer Chemoimmunotherapy.

Pharmaceutical research·2026
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026
See all related articles

Modified polyallylamine nanoparticles (PAA-IAA-PEG) demonstrate enhanced gene delivery efficiency and reduced cytotoxicity. These novel nanoparticles improve transfection rates without requiring lysosomotropic agents, offering a promising non-viral gene delivery system.

Area of Science:

  • Biomaterials Science
  • Gene Delivery Systems
  • Nanotechnology

Background:

  • Cationic polymers like polyallylamine (PAA) with primary amino groups exhibit poor transfection efficiency and high cytotoxicity.
  • Existing gene delivery methods often require specific receptor-mediated endocytosis or lysosomotropic agents for efficient gene delivery.

Purpose of the Study:

  • To chemically modify polyallylamine (PAA) by substituting primary amino groups with imidazolyl functions to enhance endosomal release.
  • To engineer PAA-imidazolyl-polyethylene glycol (PIP) nanoparticles for improved gene delivery efficiency and reduced cytotoxicity.
  • To eliminate the need for external lysosomotropic agents in gene delivery.

Main Methods:

  • PAA (17 kDa) was modified with imidazolyl moieties and cross-linked with polyethylene glycol (PEG) to form PIP nanoparticles.

Related Experiment Videos

  • Nanoparticle characterization included particle size, zeta potential, DNA accessibility, and buffering capacity.
  • In vitro transfection efficacy was assessed using enhanced green fluorescent protein (EGFP) in COS-1, N2a, and HEK293 cell lines, with cytotoxicity evaluated by MTT assay.

    • Main Results:

    • PIP nanoparticles showed several-fold increase in in vitro transfection efficiency compared to native PAA, even in serum-containing media.
    • Cell viability remained above 100% in COS-1 cells, indicating low cytotoxicity.
    • Nanoparticles exhibited a positive zeta potential (5.6–13 mV) and a size range of 185–230 nm.
    • Higher imidazolyl substitution correlated with looser DNA-nanoparticle complexes and enhanced buffering capacity.

    Conclusions:

    • PIP nanoparticles represent a novel and effective system for gene delivery.
    • The modified nanoparticles significantly improve transfection efficiency while maintaining cell viability.
    • These findings highlight the potential of PIP nanoparticles as a safe and efficient non-viral gene delivery vector.